Comments
Sanofi says Zaltrap cancer drug study positive
08.10.2012. | PARIS (Reuters) - French drugmaker Sanofi said on Monday that the results of a late-stage study of its Zaltrap drug showed a "statistically significant improvement in overall survival" in patients with colon cancer....
